- Home
- CGEN vs MED Comparison
CGEN vs MED Comparison
Compare CGEN & MED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGEN
- MED
- Stock Information
- Founded
- CGEN 1993
- MED 1980
- Country
- CGEN Israel
- MED United States
- Employees
- CGEN N/A
- MED N/A
- Industry
- CGEN Biotechnology: Biological Products (No Diagnostic Substances)
- MED Packaged Foods
- Sector
- CGEN Health Care
- MED Consumer Staples
- Exchange
- CGEN Nasdaq
- MED Nasdaq
- Market Cap
- CGEN 135.6M
- MED 139.0M
- IPO Year
- CGEN 2000
- MED N/A
- Fundamental
- Price
- CGEN $1.47
- MED $11.92
- Analyst Decision
- CGEN Strong Buy
- MED Hold
- Analyst Count
- CGEN 1
- MED 1
- Target Price
- CGEN $4.00
- MED $16.50
- AVG Volume (30 Days)
- CGEN 268.4K
- MED 253.6K
- Earning Date
- CGEN 05-19-2025
- MED 04-28-2025
- Dividend Yield
- CGEN N/A
- MED N/A
- EPS Growth
- CGEN N/A
- MED N/A
- EPS
- CGEN N/A
- MED 0.19
- Revenue
- CGEN $27,864,000.00
- MED $602,463,000.00
- Revenue This Year
- CGEN $11.81
- MED N/A
- Revenue Next Year
- CGEN $28.37
- MED N/A
- P/E Ratio
- CGEN N/A
- MED $62.74
- Revenue Growth
- CGEN N/A
- MED N/A
- 52 Week Low
- CGEN $1.13
- MED $11.88
- 52 Week High
- CGEN $2.66
- MED $36.30
- Technical
- Relative Strength Index (RSI)
- CGEN 49.50
- MED 32.66
- Support Level
- CGEN $1.13
- MED $11.88
- Resistance Level
- CGEN $1.35
- MED $13.54
- Average True Range (ATR)
- CGEN 0.11
- MED 0.64
- MACD
- CGEN 0.03
- MED -0.09
- Stochastic Oscillator
- CGEN 85.00
- MED 2.03
About CGEN Compugen Ltd.
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.
About MED MEDIFAST INC
Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. OPTAVIA provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. Medifast remains committed to its mission of offering Lifelong Transformation, Making a Healthy Lifestyle Second Nature.